These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37530337)

  • 1. Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes.
    Rao S; Epari S; Shet TM; Gujral S; Jain H; Bagal B; Senagar M; Shetty P; Moiyadi A; Goda JS; Gupta T
    Indian J Pathol Microbiol; 2023; 66(3):549-555. PubMed ID: 37530337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical subtypes of diffuse large B-cell lymphoma in the head and neck region.
    Li JM; Hou J; Li L; Wang Y
    Genet Mol Res; 2015 Apr; 14(2):3889-96. PubMed ID: 25966160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.
    Ichiki A; Carreras J; Miyaoka M; Kikuti YY; Jibiki T; Tazume K; Watanabe S; Sasao T; Obayashi Y; Onizuka M; Ohmachi K; Yoshiba F; Shirasugi Y; Ogawa Y; Kawada H; Nakamura N; Ando K
    J Clin Exp Hematop; 2017; 57(2):54-63. PubMed ID: 29021515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases.
    Sugitani A; Fukuhara S; Shibata M; Ichihara R; Furukawa H; Maeshima AM
    J Clin Exp Hematop; 2023 Sep; 63(3):181-186. PubMed ID: 37518270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical classification and prognosis of diffuse large B-cell lymphoma in China].
    Chen Y; Xiao L; Zhu X; Lu C; Yu B; Fan D; Yin Y
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):383-8. PubMed ID: 25208988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm.
    Ananthamurthy A; Murali M
    Indian J Pathol Microbiol; 2024 Jul; 67(3):564-568. PubMed ID: 38394429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas.
    Marcus C; Maragkos GA; Alterman RL; Uhlmann E; Pihan G; Varma H
    J Clin Neurosci; 2021 Jan; 83():49-55. PubMed ID: 33339691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
    Min M; Lin L; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified.
    Cho I; Yoon N; Hyeon J; Sim J; Yoo HY; Kim SJ; Kim WS; Ko YH
    Appl Immunohistochem Mol Morphol; 2020; 28(10):731-740. PubMed ID: 32287077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas.
    Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; van Wezel T; van Eijk R; Ruano D; Tensen CP; Hauben E; Woei-A-Jin FJSH; Busschots AM; van den Berg A; Diepstra A; Vermeer MH; Vermaat JSP
    Virchows Arch; 2022 Mar; 480(3):667-675. PubMed ID: 35028710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
    Chen Y; Chen H; Fu K; Zhu XZ; Irons R
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):313-8. PubMed ID: 20654154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia.
    Phang KC; Akhter A; Tizen NMS; Rahman FA; Zahratul Azma R; Elyamany G; Shabani-Rad MT; Masir N; Mansoor A
    J Clin Pathol; 2018 Mar; 71(3):215-220. PubMed ID: 28775174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm.
    Maeshima AM; Taniguchi H; Takahashi Y; Kaimi Y; Ochi T; Makino H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K
    Hum Pathol; 2024 Sep; 151():105630. PubMed ID: 39069202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining.
    Reinke S; Richter J; Fend F; Feller A; Hansmann ML; Hüttl K; Oschlies I; Ott G; Möller P; Rosenwald A; Stein H; Altenbuchinger M; Spang R; Klapper W
    Virchows Arch; 2018 Sep; 473(3):341-349. PubMed ID: 29730836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
    Choi WW; Weisenburger DD; Greiner TC; Piris MA; Banham AH; Delabie J; Braziel RM; Geng H; Iqbal J; Lenz G; Vose JM; Hans CP; Fu K; Smith LM; Li M; Liu Z; Gascoyne RD; Rosenwald A; Ott G; Rimsza LM; Campo E; Jaffe ES; Jaye DL; Staudt LM; Chan WC
    Clin Cancer Res; 2009 Sep; 15(17):5494-502. PubMed ID: 19706817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of High Ki-67 Index and Histogenetic Subclassification in Primary Central Nervous System Lymphoma.
    Cho U; Oh WJ; Hong YK; Lee YS
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):254-262. PubMed ID: 27490760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
    Montalbán C; Díaz-López A; Martín A; Baile M; Sanchez JM; Sancho JM; García O; Novelli S; Monter-Rovira A; Salar A; Bastos M; Gutiérrez A; Bento L; Córdoba R; Arquero T; González de Villambrosia S; Barranco G; De Oña R; López Guillermo A; Rodriguez Salazar MJ; Domínguez JF; Fernández R; Queizan JA; Rodríguez J; Abraira V; García JF;
    Br J Haematol; 2018 Aug; 182(4):534-541. PubMed ID: 29978453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
    Gutiérrez-García G; Cardesa-Salzmann T; Climent F; González-Barca E; Mercadal S; Mate JL; Sancho JM; Arenillas L; Serrano S; Escoda L; Martínez S; Valera A; Martínez A; Jares P; Pinyol M; García-Herrera A; Martínez-Trillos A; Giné E; Villamor N; Campo E; Colomo L; López-Guillermo A;
    Blood; 2011 May; 117(18):4836-43. PubMed ID: 21441466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.